Why are Microba Life Sciences’ (ASX:MAP) shares up 68%?

Follow us on Google News:
 Why are Microba Life Sciences’ (ASX:MAP) shares up 68%?
Image source: © Sdecoret | Megapixl.com


  • Microba’s shares shot up by 68.18% on Tuesday (29 November 2022) to trade at AU$0.37 apiece.
  • The company shared that Sonic Healthcare has bought 19.99% stake in the company for the consideration of AU$17.8 million.

The share price of Microba Life Sciences Limited (ASX:MAP) skyrocketed by a whopping 68.18% on Tuesday (29 November 2022) after the company shared that Sonic Healthcare Limited (ASX:SHL) has acquired a 19.99% strategic stake in the company for AU$17.8 million. In addition to this, Sonic is looking for shareholders’ approval to buy options for a 5% additional equity position.

The company also informed the market that Sonic and Microba have agreed on initial binding terms for a strategic alliance to offer microbiome testing technology of Microba in the United States, Switzerland, Belgium, United Kingdom, Germany, New Zealand, and Australia.

At 1:44 PM AEDT, Microba’s shares were spotted trading 68.18% higher at AU$0.37 per share with a market capitalisation of AU$60.35 million. With this, in one year, the share price has increased by 5.71%, and in six months, it has grown by 23.33%. The monthly gain is 105.56%.

About the acquisition of a strategic stake by Sonic in Microba

Under the equity subscription agreement, Sonic has acquired a 19.99% stake in Microba via the issue of new ordinary shares at AU$0.26 apiece of the issue price. With this transaction, AU$17.8 of new capital has been raised by Microba.

Moreover, Sonic seeks to buy unlisted options at an exercisable price of 33 cents per share, expiring in 18 months. These unlisted options represent 5% of the issued share capital and will raise AU$7.5 million in new capital for the company.

With the completion of this transaction, the Pro-forma cash balance of Microba as of 30 September 2022 will be AU$43.8 billion. The balance sheet would allow the organisation to advance its microbiome therapeutics, testing into the hands of patients and clinicians globally and supporting global expansion.

Strategic relationship between Microba and Sonic, details here

Sonic and Microba have entered into an agreement under which Sonic and its subsidiary companies would distribute microbiome testing products to its customers, specialists, and general practitioners for one year. The agreement would commence on 31 January 2023.

On this, Microba said,


The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Featured Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK